Shao Meng Wang
Vermögen: 34 Mio $ am 30.09.2026
Vermögen: 34 Mio $ am 30.09.2026
Dr. Shao Meng Wang is a Non-Executive Director at Ascentage Pharma Group International Co., Ltd. and a Director & Chief Scientific Officer at Jiangsu Yasheng Pharmaceutical Development Co. Ltd. He is on the Board of Directors at Ascentage Pharma Group International Co., Ltd., Jiangsu Yasheng Pharmaceutical Development Co. Ltd., Ascentage International Ltd., Medsyn Biopharma LLC, Oncopia Therapeutics, Inc. and Rogel Cancer Center: University of Michigan.
Dr. Wang was previously employed as an Editor-in-Chief by Journal of Medicinal Chemistry, a Co-Founder by Oncofusion Therapeutics, Inc., a Founder by Ascentage Pharma Group Corp.
Ltd., a Co-Founder by Ascenta Therapeutics, Inc., a Professor by University of Michigan, and an Assistant Professor by Georgetown University.
He received his undergraduate degree from Peking University and a doctorate degree from Case Western Reserve University.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 20.04.2026 | 8’565’823 ( 2.29% ) | 34 Mio $ | 30.09.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| ASCENTAGE PHARMA GROUP INTERNATIONAL | Gründer | 01.05.2009 |
Jiangsu Yasheng Pharmaceutical Development Co. Ltd.
Jiangsu Yasheng Pharmaceutical Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs | Gründer | 01.01.2009 |
Medsyn Biopharma LLC
Medsyn Biopharma LLC BiotechnologyHealth Technology Develops cancer therapeutics | Gründer | - |
Oncopia Therapeutics, Inc.
Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Direktor/Vorstandsmitglied | - |
Rogel Cancer Center: University of Michigan
Rogel Cancer Center: University of Michigan Medical/Nursing ServicesHealth Services Provides healthcare services for cancer patients | Direktor/Vorstandsmitglied | - |
Ascentage International Ltd. | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Journal of Medicinal Chemistry | Corporate Officer/Principal | 01.12.2020 |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01.01.2000 |
Ascentage Pharma Group Corp. Ltd.
Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Gründer | - |
| ░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░░░░░ ░░ ░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 14 |
|---|---|
Oncofusion Therapeutics, Inc.
Oncofusion Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops personalized therapeutics for patients with genetically defined cancers | Health Technology |
Peking University
Peking University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Case Western Reserve University
Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ascenta Therapeutics, Inc.
Ascenta Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer | Health Technology |
Georgetown University
Georgetown University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Jiangsu Yasheng Pharmaceutical Development Co. Ltd.
Jiangsu Yasheng Pharmaceutical Development Co. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that develops drugs | Health Technology |
Ascentage Pharma Group International Co., Ltd.
Ascentage Pharma Group International Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering, developing and commercializing of therapies for hematological malignancies | Health Technology |
Oncopia Therapeutics, Inc.
Oncopia Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Engages in conducting research in biotechnology | Commercial Services |
Medsyn Biopharma LLC
Medsyn Biopharma LLC BiotechnologyHealth Technology Develops cancer therapeutics | Health Technology |
Rogel Cancer Center: University of Michigan
Rogel Cancer Center: University of Michigan Medical/Nursing ServicesHealth Services Provides healthcare services for cancer patients | Health Services |
Journal of Medicinal Chemistry | |
Ascentage International Ltd. | |
Ascentage Pharma Group Corp. Ltd.
Ascentage Pharma Group Corp. Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen